Assessment of the Body Composition and Parameters of the Cardiovascular Risk in Juvenile Idiopathic Arthritis

Table 2

Characteristics of patients with JIA according to disease activity.

	JIA inactive,	JIA active,	Control group,
Age, years	13,7 ± 1,8	14,2 ± 1,8	14,4 ± 1,8	0.5762
Female	10 (90,9%)	13 (68,4%)	15 (75%)	0.4066
Weight, kg	47,7 ± 10,2	48,7 ± 7,8	55,5 ± 9,0	0.0248; CG versus I: 0.0582; CG versus A: 0.0516
Height, cm	159,3 ± 10,3	161,5 ± 8,1	166,0 ± 10,3	0.1428
BMI	18,6 ± 2,6	18,6 ± 2,0	20,1 ± 2,3	0.0979
BMI percentile	39,6 ± 22,7	35,8 ± 24,6	52,9 ± 25,6	0.0917
FAT %	21,0 ± 5,4	19,3 ± 6,0	23,0 ± 5,5	0.1293
Total cholesterol, mg/dL	156,6 ± 27,8	148,3 ± 23,6	153,4 ± 26,8	0.6770
Triglycerides, mg/dL	92,3 ± 42,6	87,7 ± 37,5	92,1 ± 37,3	0.9266
LDL cholesterol, mg/dL	74,8 ± 21,8	79,2 ± 25,1	77,6 ± 23,9	0.8909
HDL cholesterol, mg/dL	63,4 ± 13,5	55,6 ± 13,4	57,4 ± 14,9	0.3435
hsCRP, mg/L	0,30 0,20–0,50	0,70 0,40–3,90	0,45 0,30–0,70	0.0154^*; I versus A: 0.0109
IL-6, pg/mL	0,0 0,0–369,6	168,4 0,0–255,9	0,0 0,0-0,0	0.0384^*; CG versus A: 0.0109
Homocysteine, µmol/L	8,6 ± 2,6	9,1 ± 3,0	9,2 ± 2,5	0.8191
IMT, mm	0,49 ± 0,05	0,46 ± 0,03	0,47 ± 0,04	0.1796

BMI: body mass index, FAT %: % body fat, LDL: low density lipoprotein, HDL: high density lipoprotein, hsCRP: high sensitivity lipoprotein, IL-6: interleukin 6, IMT: intima media thickness, ^*statistically significant, CG: control group, I: inactive, and A: active.